{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:17:13Z","timestamp":1788257833343,"version":"build-2803163510"},"reference-count":71,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>This study systematically explored immune targets in gastric adenocarcinoma (GAC) suitable for mRNA vaccine development. Based on multi-omics data from public databases, we first screened a set of potential tumor-associated antigen genes. Subsequently, using ten machine learning algorithms, we constructed 101 prognostic models and, through optimization and comparison, selected the Random Survival Forest (RSF) method to establish a clinical prognostic model for GAC consisting of seven genes (TYMP, IFGN, ITGAX, GBP5, GBP4, STAT1, CD84). At both the genetic and protein levels, these genes were closely associated with the antigen presentation process, suggesting the potential functional role of this model in antigen presentation. Further analysis of the immune infiltration characteristics in GAC preliminarily revealed its possible immune evasion mechanisms. Building on this, we designed candidate mRNA vaccine templates for GAC using the mRNAdesigner platform. Additionally, this study investigated the potential roles of the above seven genes in GAC progression and screened small-molecule compounds targeting these genes. Molecular dynamics simulations (MD) were performed to verify the binding stability between these compounds and their corresponding proteins. This study comprehensively simulated the tumor microenvironment (TME) and antigen presentation process in GAC, evaluated the clinical translation potential of the neoantigen prognostic model and its predictive value for immunotherapy, and provided a preliminary design scheme for an mRNA vaccine against GAC. The findings offer new evidence for identifying immune therapy targets in GAC and are expected to advance the development of immunotherapy strategies for GAC.<\/jats:p>","DOI":"10.3390\/ijms27177712","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:48:36Z","timestamp":1788256116000},"page":"7712","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Construction of a Neoantigen Prognostic Model for Gastric Adenocarcinoma Based on Multi-Omics Data Mining and the Design of mRNA Vaccines and Targeted Drugs"],"prefix":"10.3390","volume":"27","author":[{"given":"Jiaxiang","family":"Liang","sequence":"first","affiliation":[{"name":"Tumor and Aging Laboratory, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8674-7629","authenticated-orcid":false,"given":"Zhipeng","family":"Xie","sequence":"additional","affiliation":[{"name":"Tumor and Aging Laboratory, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Yingjie","family":"Sun","sequence":"additional","affiliation":[{"name":"Tumor and Aging Laboratory, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"}]},{"given":"Yuheng","family":"Tang","sequence":"additional","affiliation":[{"name":"Tumor and Aging Laboratory, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"software","vocabulary":"credit"}]},{"given":"Samina","family":"Gul","sequence":"additional","affiliation":[{"name":"Tumor and Aging Laboratory, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"software","vocabulary":"credit"}]},{"given":"Qi","family":"Qi","sequence":"additional","affiliation":[{"name":"Tumor and Aging Laboratory, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"}]},{"given":"Jianyu","family":"Pang","sequence":"additional","affiliation":[{"name":"Tumor and Aging Laboratory, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0458-4368","authenticated-orcid":false,"given":"Yongzhi","family":"Chen","sequence":"additional","affiliation":[{"name":"Tumor and Aging Laboratory, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5427-0514","authenticated-orcid":false,"given":"Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"Tumor and Aging Laboratory, Kunming University of Science and Technology, Kunming 650500, China"},{"name":"School of Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"}]},{"given":"Jiehui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Tumor and Aging Laboratory, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0769-6448","authenticated-orcid":false,"given":"Wenru","family":"Tang","sequence":"additional","affiliation":[{"name":"Tumor and Aging Laboratory, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Xuhong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Office of Science and Technology, Yunnan University of Chinese Medicine, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Qin, N., Fan, Y., Yang, T., Yang, Z., and Fan, D. (2025). The burden of Gastric Cancer and possible risk factors from 1990 to 2021, and projections until 2035: Findings from the Global Burden of Disease Study 2021. Biomark. Res., 13.","DOI":"10.1186\/s40364-024-00720-8"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/S0140-6736(16)30354-3","article-title":"Gastric cancer","volume":"388","author":"Sagaert","year":"2016","journal-title":"Lancet"},{"key":"ref_4","unstructured":"Japanese Gastric Cancer Association (2021). Japanese Gastric Cancer Treatment Guidelines 2018, Japanese Gastric Cancer Association. [5th ed.]. Gastric Cancer."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","article-title":"Global surveillance of cancer survival 1995\u20132009: Analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)","volume":"385","author":"Allemani","year":"2015","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ccell.2022.10.013","article-title":"Challenges in neoantigen-directed therapeutics","volume":"41","author":"Lybaert","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41571-024-00902-1","article-title":"Cancer mRNA vaccines: Clinical advances and future opportunities","volume":"21","author":"Sayour","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Miao, L., Zhang, Y., and Huang, L. (2021). mRNA vaccine for cancer immunotherapy. Mol. Cancer, 20.","DOI":"10.1186\/s12943-021-01335-5"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00262-018-2257-2","article-title":"Phase I\/II clinical trial of a Wilms\u2019 tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer","volume":"68","author":"Zhang","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/bfgp\/ely019","article-title":"Immunotherapy for gastric cancer: Dilemmas and prospect","volume":"18","author":"Zhao","year":"2019","journal-title":"Brief. Funct. Genom."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"K\u00fcbler, H., Scheel, B., Gnad-Vogt, U., Miller, K., Schultze-Seemann, W., Dorp, F.V., Parmiani, G., Hampel, C., Wedel, S., and Trojan, L. (2015). Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: A first-in-man phase I\/IIa study. J. Immunother. Cancer, 3.","DOI":"10.1186\/s40425-015-0068-y"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00262-019-02315-x","article-title":"A phase I\/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB\/IV non-small cell lung cancer","volume":"68","author":"Sebastian","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Esprit, A., de Mey, W., Bahadur Shahi, R., Thielemans, K., Franceschini, L., and Breckpot, K. (2020). Neo-Antigen mRNA Vaccines. Vaccines, 8.","DOI":"10.3390\/vaccines8040776"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Treese, C., Hartl, K., P\u00f6tzsch, M., Dahlmann, M., von Winterfeld, M., Berg, E., Hummel, M., Timm, L., Rau, B., and Walther, W. (2022). S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and Esophagus. Cells, 11.","DOI":"10.3390\/cells11061056"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41586-021-04161-3","article-title":"The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer","volume":"600","author":"Janjigian","year":"2021","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gut.2010.230623","article-title":"Gastrokine 1 induces senescence through p16\/Rb pathway activation in gastric cancer cells","volume":"61","author":"Xing","year":"2012","journal-title":"Gut"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Wang, J., Liu, T., Huang, T., Shang, M., and Wang, X. (2022). The mechanisms on evasion of anti-tumor immune responses in gastric cancer. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.943806"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zhou, J., Li, J., Chen, J., Lan, X., Ai, Y., Liu, P., Peng, J., Pan, X., Zhang, Y., and Zhang, H. (2025). Decoding inflammatory mediators in the Correa\u2019s cascade: From chronic gastritis to carcinogenesis and targeted therapies. Int. Immunopharmacol., 162.","DOI":"10.1016\/j.intimp.2025.115191"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network (2014). Comprehensive molecular characterization of gastric adenocarcinoma. Nature, 513, 202\u2013209.","DOI":"10.1038\/nature13480"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Duan, Y., Xu, Y., Dou, Y., and Xu, D. (2025). Helicobacter pylori and gastric cancer: Mechanisms and new perspectives. J. Hematol. Oncol., 18.","DOI":"10.1186\/s13045-024-01654-2"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41575-022-00591-0","article-title":"The immune microenvironment in gastric adenocarcinoma","volume":"19","author":"Zavros","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014A new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/med.20159","article-title":"The dual role of thymidine phosphorylase in cancer development and chemotherapy","volume":"29","author":"Bronckaers","year":"2009","journal-title":"Med. Res. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2019.07.019","article-title":"Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade","volume":"178","author":"Benci","year":"2019","journal-title":"Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s002620050511","article-title":"Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line","volume":"47","author":"Abril","year":"1998","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Hu, J., Cao, J., Huang, S., and Chen, Y. (2024). ITGAX promotes gastric cancer progression via epithelial-mesenchymal transition pathway. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1536478"},{"key":"ref_28","first-page":"1310","article-title":"Guanylate binding protein 5 accelerates gastric cancer progression via the JAK1-STAT1\/GBP5\/CXCL8 positive feedback loop","volume":"13","author":"Cao","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Liu, Y., Huang, Y., He, Q., Shen, Y., and Wang, Y. (2025). Dual regulation of gastrointestinal tumor progression by the IFN-\u03b3\/STAT1 pathway and prospects for targeted therapy. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1598170"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Li, X., Pan, K., Vieth, M., Gerhard, M., Li, W., and Mej\u00edas-Luque, R. (2022). JAK-STAT1 Signaling Pathway Is an Early Response to Helicobacter pylori Infection and Contributes to Immune Escape and Gastric Carcinogenesis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23084147"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/cbin.70074","article-title":"Exploring SLAMF5\/CD84 in Cancer: Advancing the Frontiers of Tumor Immunology","volume":"49","author":"Rab","year":"2025","journal-title":"Cell Biol. Int."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Ponzo, M., Drufuca, L., Buracchi, C., Sindoni, M.M., Nucera, S., Bugarin, C., Bason, R., Rossetti, G., Bonnal, R., and Meli, C. (2025). Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance. J. Immunother. Cancer, 13.","DOI":"10.1136\/jitc-2025-011768"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Ruiz-Iglesias, A., Guilbaud, E., Galluzzi, L., and Ma\u00f1es, S. (2025). Context-dependent impact of type I interferon signaling in cancer. Mol. Cancer, 24.","DOI":"10.1186\/s12943-025-02495-4"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Zou, D., Hu, J., Wang, Y., He, P., Gao, L., Ma, H., Yan, Y., Li, Y., Wang, K., and Chen, W. (2026). Decoding the role of LRP1 in cancers: From molecular mechanisms to therapeutic opportunities. Crit. Rev. Oncol. Hematol., 219.","DOI":"10.1016\/j.critrevonc.2026.105122"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Xia, Y., Huang, C., Zhong, M., Zhong, H., Ruan, R., Xiong, J., Yao, Y., Zhou, J., and Deng, J. (2025). Targeting HGF\/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion. Cell Commun. Signal., 23.","DOI":"10.1186\/s12964-025-02033-1"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Li, W., Li, K., Chen, Y., Wang, S., Xu, K., Ye, S., Zhao, B., Yuan, H., Li, Z., and Shen, Y. (2025). IRF1 transcriptionally up-regulates CXCL10 which increases CD8(+) T cells infiltration in colorectal cancer. Int. Immunopharmacol., 144.","DOI":"10.1016\/j.intimp.2024.113678"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.mie.2019.04.010","article-title":"Quantification of eIF2alpha phosphorylation during immunogenic cell death","volume":"629","author":"Bezu","year":"2019","journal-title":"Methods Enzymol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Ziogas, D.C., Theocharopoulos, C., Lialios, P.-P., Foteinou, D., Koumprentziotis, I.-A., Xynos, G., and Gogas, H. (2023). Beyond CTLA-4 and PD-1 Inhibition: Novel Immune Checkpoint Molecules for Melanoma Treatment. Cancers, 15.","DOI":"10.3390\/cancers15102718"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Nip, C., Wang, L., and Liu, C. (2023). CD200\/CD200R: Bidirectional Role in Cancer Progression and Immunotherapy. Biomedicines, 11.","DOI":"10.3390\/biomedicines11123326"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1124\/pharmrev.123.001028","article-title":"The Art of Finding the Right Drug Target: Emerging Methods and Strategies","volume":"76","author":"Jia","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Kennecke, H., Zell, J., Pham, H., Simianu, V., Herz, K., Kelley, A., Carmichael, J., Hochster, H., and Kachnic, L. (2025). Results of a phase II trial of short-course radiation and TASOX [trifluridine\/tipiracil (TAS-102) plus oxaliplatin] chemotherapy in operable rectal cancer. ESMO Gastrointest. Oncol., 9.","DOI":"10.1016\/j.esmogo.2025.100215"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Taub, J.W., Buck, S.A., Xavier, A.C., Edwards, H., Matherly, L.H., and Ge, Y. (2024). The evolution and history of Vinca alkaloids: From the Big Bang to the treatment of pediatric acute leukemia. Pediatr. Blood Cancer, 71.","DOI":"10.1002\/pbc.31247"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cac2.12516","article-title":"The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023","volume":"44","author":"Wang","year":"2024","journal-title":"Cancer Commun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF01803787","article-title":"The efficacy of 9-cis retinoic acid in experimental models of cancer","volume":"38","author":"Gottardis","year":"1996","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1182\/blood-2014-03-559963","article-title":"The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma","volume":"124","author":"Spencer","year":"2014","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000011923","article-title":"Topotecan\u2014A novel topoisomerase I inhibitor: Pharmacology and clinical experience","volume":"56","author":"Kollmannsberger","year":"1999","journal-title":"Oncology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1525-1438.2007.01003.x","article-title":"Topotecan in cervical cancer","volume":"17","author":"Ackermann","year":"2007","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1440-1681.1998.tb02339.x","article-title":"5-fluorouracil: A pharmacological paradigm in the use of cytotoxics","volume":"25","author":"Thomas","year":"1998","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Valencia-Lazcano, A.A., Hassan, D., Pourmadadi, M., Shamsabadipour, A., Behzadmehr, R., Rahdar, A., Medina, D.I., and D\u00edez-Pascual, A.M. (2023). 5-Fluorouracil nano-delivery systems as a cutting-edge for cancer therapy. Eur. J. Med. Chem., 246.","DOI":"10.1016\/j.ejmech.2022.114995"},{"key":"ref_50","first-page":"3438","article-title":"[Prednisone]","volume":"100","author":"Lindeboom","year":"1956","journal-title":"Ned. Tijdschr. Voor Geneeskd."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(10)61389-X","article-title":"Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: A randomised open-label trial","volume":"376","author":"Oudard","year":"2010","journal-title":"Lancet"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Amaya-Ramirez, D., Martinez-Enriquez, L.C., and Parra-L\u00f3pez, C. (2023). Usefulness of Docking and Molecular Dynamics in Selecting Tumor Neoantigens to Design Personalized Cancer Vaccines: A Proof of Concept. Vaccines, 11.","DOI":"10.3390\/vaccines11071174"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1021\/acs.jpcb.2c04346","article-title":"AlphaFold, Artificial Intelligence (AI), and Allostery","volume":"126","author":"Ruth","year":"2022","journal-title":"J. Phys. Chem. B"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Li, X., Zhu, Y.-J., Xue, Y., Chen, T.-T., Sun, X.-K., and Shi, H.-Y. (2025). Neoantigen-Based Immunotherapy in Lung Cancer: Advances, Challenges and Prospects. Cancers, 17.","DOI":"10.3390\/cancers17121953"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","article-title":"The Gene Expression Omnibus Database","volume":"1418","author":"Clough","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"ref_56","unstructured":"(2022). CNCB-NGDC Members and Partners. Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2022. Nucleic Acids Res., 50, D27\u2013D38."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-1-4939-3578-9_6","article-title":"A Practical Guide to The Cancer Genome Atlas (TCGA)","volume":"1418","author":"Wang","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s12026-014-8516-1","article-title":"ImmPort: Disseminating data to the public for the future of immunology","volume":"58","author":"Bhattacharya","year":"2014","journal-title":"Immunol. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"D870","DOI":"10.1093\/nar\/gkac947","article-title":"CellMarker 2.0: An updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data","volume":"51","author":"Hu","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Reel, P.S., Reel, S., Pearson, E., Trucco, E., and Jefferson, E. (2021). Using machine learning approaches for multi-omics data analysis: A review. Biotechnol. Adv., 49.","DOI":"10.1016\/j.biotechadv.2021.107739"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Ma, Y., Jin, J., Xue, Z., Zhao, J., Cai, W., and Zhang, W. (2024). Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric Cancer. J. Transl. Med., 22.","DOI":"10.1186\/s12967-024-05109-7"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/TP.0000000000002923","article-title":"Seeing the Forest for the Trees: Random Forest Models for Predicting Survival in Kidney Transplant Recipients","volume":"104","author":"Kaplan","year":"2020","journal-title":"Transplantation"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Bozoky, B., Szekely, L., Ernberg, I., and Savchenko, A. (2022). AtlasGrabber: A software facilitating the high throughput analysis of the human protein atlas online database. BMC Bioinform., 23.","DOI":"10.1186\/s12859-022-05097-9"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"W415","DOI":"10.1093\/nar\/gkaf410","article-title":"mRNAdesigner: An integrated web server for optimizing mRNA design and protein translation in eukaryotes","volume":"53","author":"Mo","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"D1257","DOI":"10.1093\/nar\/gkac833","article-title":"Comparative Toxicogenomics Database (CTD): Update 2023","volume":"51","author":"Davis","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"D400","DOI":"10.1093\/nar\/gkr1132","article-title":"PubChem\u2019s BioAssay Database","volume":"40","author":"Wang","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_70","unstructured":"UniProt Consortium (2023). UniProt: The Universal Protein Knowledgebase in 2023. Nucleic Acids Res., 51, D523\u2013D531."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: Fast, flexible, and free","volume":"26","author":"Lindahl","year":"2005","journal-title":"J. Comput. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7712\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:49:30Z","timestamp":1788256170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":71,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27177712"],"URL":"https:\/\/doi.org\/10.3390\/ijms27177712","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]}}}